{"organizations": [], "uuid": "282d5e0da40a0ded9c6abff18cb76d540e09a876", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-say/brief-shandong-xinhua-pharmaceutical-says-h-share-trading-to-continue-idUSFWN1PJ0V0", "country": "US", "domain_rank": 408, "title": "BRIEF-Shandong Xinhua Pharmaceutical Says H Share Trading To Continue", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.024, "site_type": "news", "published": "2018-01-24T20:35:00.000+02:00", "replies_count": 0, "uuid": "282d5e0da40a0ded9c6abff18cb76d540e09a876"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shandong-xinhua-pharmaceutical-say/brief-shandong-xinhua-pharmaceutical-says-h-share-trading-to-continue-idUSFWN1PJ0V0", "ord_in_thread": 0, "title": "BRIEF-Shandong Xinhua Pharmaceutical Says H Share Trading To Continue", "locations": [], "entities": {"persons": [], "locations": [{"name": "shenzhen", "sentiment": "none"}], "organizations": [{"name": "shandong xinhua pharmaceutical co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "xinhua pharmaceutical says h share trading to continue", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :\n* ‍APPLIED TO SHENZHEN STOCK EXCHANGE FOR SUSPENSION OF TRADING OF A SHARES ON SZSE WITH EFFECT FROM 25 JAN 2018​\n* TRADING OF H SHARES OF CO WILL NOT BE AFFECTED AND WILL CONTINUE\n* TO RESUME A SHARE TRADING AFTER REVIEWING & APPROVING PLAN TO ISSUE CONSIDERATION SHARES FOR POTENTIAL ACQUISITION​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T20:35:00.000+02:00", "crawled": "2018-01-25T12:55:14.006+02:00", "highlightTitle": ""}